One More Wrinkle in Battle for Botox Firm Allergan

Allergan approached Salix Pharmaceuticals and at least one other company about a potential acquisition, as the Botox maker seeks to fend off a $53 billion hostile takeover from Valeant Pharmaceuticals.



from WSJ.com: US Business http://ift.tt/YvnnoB

via IFTTT